Nine UCL academics elected to Academy Medical Sciences

The fifty newly elected Fellows of the Academy of Medical Sciences (AMS) includes nine academics from UCL, in recognition of the incredible contributions they have made to medical science.

These Fellows have been chosen for their outstanding efforts in the field of biomedical science, including national science engagement and communication programmes, research discoveries and translating scientific advancements into benefits for public healthcare.

The academics from UCL are:

Professor Ibrahim Abubakar (UCL Institute for Global Health) 

In addition to his role as Director of the UCL Institute for Global Health, Prof Abubakar’s work focuses on the epidemiology, prevention and treatment of infections including hepatitides, tuberculosis, HIV, as well as antimicrobial resistance and vaccine-preventable diseases among underserved populations. 

Professor James Bainbridge (UCL Institute of Ophthalmology)

Having performed the world’s first gene replacement surgery for inherited blindness, Professor Bainbridge’s aim is to reduce blindness by developing new treatments for retinal diseases.

Professor Paolo De Coppi (UCL Great Ormond Street Institute of Child Health)

Professor De Coppi’s research aims to better understand the abnormal and normal development of the gastrointestinal tract’s neuromuscular components, in addition to a focus on the development of new stem cell-based therapies for aganglionic disorders of the gut.

Professor Diana Gibb (MRC Clinical Trials Unit at UCL) 

Having coordinated multi-country paediatric HIV trials across Europe, Thailand and South America since the 1990s, Professor Gibb’s research examines tuberculosis, malaria and antimicrobial resistance, with a focus on the suitability of children’s medicines to the setting.

Professor Alison Lloyd (MRC Lab for Molecular Cell Biology at UCL)

By combining primary in vitro culture systems and in vivo mouse models, Professor Lloyd’s research studies the cellular and molecular mechanisms underlying the homeostatic regulation of the cell growth and regeneration of Schwann cells.

Professor Emma Morris (UCL Infection & Immunity) 

Professor Morris’s research examines new approaches for antigen-specific T cells for cancer immunotherapy and leukaemia, as well as looking at the retroviral gene transfer of TCR genes into T cells, and the analysis of signalling pathways of tumour antigen-specific TCR cells.

Professor Rosalind Raine (UCL Epidemiology & Health)

Professor Raine’s research designs and evaluate strategies to reduce the social gradient in the use of health services, and is working to improve team meetings for patients with chronic diseases.

Professor Mary Reilly (UCL Queen Square Institute of Neurology)

Professor Reilly’s research has explored the inherited neuropathies with a focus on translational research, and currently is part of a programme on human gene identification and analysis.

Professor Bart De Strooper (UK Dementia Research Institute at UCL)

A world-renowned Alzheimer’s researcher, Professor De Strooper’s research aims to understand the mechanisms which fundamentally underlie Parkinson’s and Alzheimer’s disease.

Commenting on UCL’s nine new AMS Fellows, Professor David Lomas, UCL Vice Provost (Health), said: "I am delighted that so many colleagues have been elected to the highly respected Academy Fellowship. The new UCL affiliated members have each made outstanding contributions to biomedical science and these fellowships are well deserved recognition of their remarkable work.

The range of disciplines represented, from global health to paediatric surgery, is testament to the quality and breadth of the work being done across the UCL School of Life and Medical Sciences. I am immensely proud."

Professor Sir Robert Lechler PMedSci, President of the Academy of Medical Sciences said:

"I am delighted to welcome these 50 new Fellows into the Academy’s Fellowship. Each one has made their own outstanding contribution to biomedical science, and together they are advancing the health of our society in the UK and internationally. Their work affects us all, from the way we keep healthy through our lifestyle, to how we are treated if we become ill, to the way we receive information about health."

The new Fellows will be formally admitted to the Academy on 25 June 2020.

This site uses cookies and analysis tools to improve the usability of the site. More information. |